An Oxford-based venture capital firm has received £15 million in investment.
Aviva Investors, the global asset management business of Aviva, has injected the money into Oxford Science Enterprises (OSE).
OSE is an independent investment company that supports science and technology companies across life sciences, health tech, and deep tech.
It is dedicated to transforming scientific research into global innovations through a partnership with the University of Oxford.
Since its inception in 2015, it has raised more than £850 million and collaborated with more than 300 international investors, collectively deploying more than £2.5 billion into more than 100 university spin-out companies.
Aviva Investors has also invested more than £6.6 million directly in Alloyed, one of OSE’s portfolio companies which specialises in designing and manufacturing advanced alloys.
Ben Luckett, managing director of venture and strategic capital at Aviva Investors, said: “Our strategic partnership with OSE is a further example of our investment philosophy and commitment to support innovative high-growth science and technology companies in the Oxford-Cambridge growth corridor that are helping the UK get ready for the future.
“This investment in Alloyed highlights the value of forming these partnerships with university-affiliated funds and how they can provide direct access to attractive and IP-rich university spin-outs at the growth stage.
“For investors prepared to commit long-term capital as these companies scale up, these partnerships are crucial to maximising the potential for investment returns.”
